A phase 2 multiple ascending dose study of the inhaled pan-JAK inhibitor nezulcitinib (TD-0903) in severe COVID-19

Singh, Dave ; Bogus, Maxim ; Moskalenko, Valentyn ; Lord, Robert ; Moran, Edmund J ; Crater, Glenn D ; Bourdet, David L ; Pfeifer, Nathan D ; Woo, Jacky ; Kaufman, Elad ; Lombardi, David A ; Weng, Emily Y ; Nguyen, Tuan ; Woodcock, Ashley ; Haumann, Brett ; Saggar, Rajeev

The European respiratory journal, 2021-10, Vol.58 (4), p.2100673 [Peer Reviewed Journal]

England: European Respiratory Society

Full text available